Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy
Ksenya Shchors(Cancer Research Institute), Gérard I. Evan(King's College - North Carolina), Douglas Hanahan(Ludwig Cancer Research), Lamorna Brown Swigart(University of California, San Francisco), Tarık Tihan(University of California, San Francisco), William A. Weiss(City College of San Francisco), Natalya Lyubynska(Pediatrics and Genetics), Anders I. Persson(University of California, San Francisco), Fanya Rostker(Apath (United States)), Nan Li(Zunyi Medical University), Mitchel S. Berger(University of California, San Francisco)
Cited by 47
Related Papers
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
|Cancer Cell|2012|4.7k
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k